Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes: A Single-group, Clinical Interventional Study

Overview

Journal Rev Recent Clin Trials

Specialties General Medicine
Pharmacology

Date 2024 Apr 1

PMID 38561621

Authors

Mahmoud Parham

Gholam Reza Tavasoli

Shahram Arsang-Jang

Mohammad Amin Habibi

Davood Olad Dameshgi

Mohammad Reza Pashaei

Sajjad Ahmadpour

Jamshid Vafaeimanesh

Affiliations

Soon will be listed here.

Abstract

Aims: Iron deficiency anemia (IDA) is one of the disorders recently associated with an increase in insulin resistance (IR) and, consequently, diabetes mellitus (DM) affection by causing oxidative stress. In this study, we look at how IDA may contribute to developing type II diabetes mellitus (T2DM), controlling diabetes, and reducing IR in women with T2DM.

Methods: In this single group, clinical interventional study, we enrolled 40 women with T2DM and IDA. Before and after intervention with ferrous sulfate tablets, their blood glucose (BG) levels and IR levels were evaluated. This study was approved by the Ethics Committee of Qom University of Medical Sciences (ethics code: IR.MUQ.REC.1397.031) and registered at the Iranian Center for Clinical Trials (No. IRCT20170215032587N3). A significant level was considered p <0.05.

Result: The mean age of patients was 48.18 ± 4.6 years, with 5.3-5.8 years duration of T2DM. After the intervention, the mean fasting blood glucose (FBG) level reached 198.53 ± 48.11 to 170.93 ± 37.41, which was significant (p <0.0001). Also, hemoglobin A1C level reached from 8.49 ± 0.9 to 7.96 ± 0.58, which was significant (p <0.0001). Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) demonstrating a significant reduction of IR levels after intervention with ferrous sulfate tablets (p <0.018).

Conclusions: IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients.

References

Rashedi V, Asadi-Lari M, Delbari A, Fadayevatan R, Borhaninejad V, Foroughan M . Prevalence of diabetes type 2 in older adults: Findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes Metab Syndr. 2017; 11 Suppl 1:S347-S350. DOI: 10.1016/j.dsx.2017.03.014. View

Gromova L, Fetissov S, Gruzdkov A . Mechanisms of Glucose Absorption in the Small Intestine in Health and Metabolic Diseases and Their Role in Appetite Regulation. Nutrients. 2021; 13(7). PMC: 8308647. DOI: 10.3390/nu13072474. View

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009; 32 Suppl 1:S62-7. PMC: 2613584. DOI: 10.2337/dc09-S062. View

Dilworth L, Facey A, Omoruyi F . Diabetes Mellitus and Its Metabolic Complications: The Role of Adipose Tissues. Int J Mol Sci. 2021; 22(14). PMC: 8305176. DOI: 10.3390/ijms22147644. View

Fahed M, Abou Jaoudeh M, Merhi S, Mosleh J, Ghadieh R, Al Hayek S . Evaluation of risk factors for insulin resistance: a cross sectional study among employees at a private university in Lebanon. BMC Endocr Disord. 2020; 20(1):85. PMC: 7288486. DOI: 10.1186/s12902-020-00558-9. View

Semple R, Savage D, Cochran E, Gorden P, ORahilly S . Genetic syndromes of severe insulin resistance. Endocr Rev. 2011; 32(4):498-514. DOI: 10.1210/er.2010-0020. View

Newsholme P, Cruzat V, Keane K, Carlessi R, Homem de Bittencourt Jr P . Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016; 473(24):4527-4550. DOI: 10.1042/BCJ20160503C. View

Maamoun H, Benameur T, Pintus G, Munusamy S, Agouni A . Crosstalk Between Oxidative Stress and Endoplasmic Reticulum (ER) Stress in Endothelial Dysfunction and Aberrant Angiogenesis Associated With Diabetes: A Focus on the Protective Roles of Heme Oxygenase (HO)-1. Front Physiol. 2019; 10:70. PMC: 6378556. DOI: 10.3389/fphys.2019.00070. View

Barone E, Di Domenico F, Perluigi M, Butterfield D . The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease. Free Radic Biol Med. 2021; 176:16-33. PMC: 8595768. DOI: 10.1016/j.freeradbiomed.2021.09.006. View

10.

Rehman K, Akash M . Mechanism of Generation of Oxidative Stress and Pathophysiology of Type 2 Diabetes Mellitus: How Are They Interlinked?. J Cell Biochem. 2017; 118(11):3577-3585. DOI: 10.1002/jcb.26097. View

11.

Ma X, Cui Z, Du Z, Lin H . Transforming growth factor-β signaling, a potential mechanism associated with diabetes mellitus and pancreatic cancer?. J Cell Physiol. 2020; 235(9):5882-5892. DOI: 10.1002/jcp.29605. View

12.

Davies M, Aroda V, Collins B, Gabbay R, Green J, Maruthur N . Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022; 65(12):1925-1966. PMC: 9510507. DOI: 10.1007/s00125-022-05787-2. View

13.

Tasali E, Wroblewski K, Kahn E, Kilkus J, Schoeller D . Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings: A Randomized Clinical Trial. JAMA Intern Med. 2022; 182(4):365-374. PMC: 8822469. DOI: 10.1001/jamainternmed.2021.8098. View

14.

Sondrup N, Termannsen A, Eriksen J, Hjorth M, Faerch K, Klingenberg L . Effects of sleep manipulation on markers of insulin sensitivity: A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2022; 62:101594. DOI: 10.1016/j.smrv.2022.101594. View

15.

Cheung C, Cheung T, Lam K, Cheung B . High ferritin and low transferrin saturation are associated with pre-diabetes among a national representative sample of U.S. adults. Clin Nutr. 2013; 32(6):1055-60. DOI: 10.1016/j.clnu.2012.11.024. View

16.

Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L . Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr Med Chem. 2009; 16(1):113-29. DOI: 10.2174/092986709787002862. View

17.

Fernandez-Real J, McClain D, Manco M . Mechanisms Linking Glucose Homeostasis and Iron Metabolism Toward the Onset and Progression of Type 2 Diabetes. Diabetes Care. 2015; 38(11):2169-76. DOI: 10.2337/dc14-3082. View

18.

Fernandez-Real J, Lopez-Bermejo A, Ricart W . Cross-talk between iron metabolism and diabetes. Diabetes. 2002; 51(8):2348-54. DOI: 10.2337/diabetes.51.8.2348. View

19.

Coban E, Ozdogan M, Timuragaoglu A . Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004; 112(3):126-8. DOI: 10.1159/000079722. View

20.

Davis R, McCann V, Nicol D . Influence of iron-deficiency anaemia on the glycosylated haemoglobin level in a patient with diabetes mellitus. Med J Aust. 1983; 1(1):40-1. DOI: 10.5694/j.1326-5377.1983.tb136024.x. View